Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Legal Address
Gedung Tempo Scan Tower,Jl. H.R. Rasuna Said Kav. 3-4
Jakarta; Jakarta; Map
Postal Code: 12950
Tel: +62-21-2921-
Fax: +62-21-2920-
Website: http://www.pttempo.com

Full name: Pt Tempo Scan Pacific Tbk

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
EMISid: 1612141
ISIN: ID1000104508
Incorporation Date: 1970

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing

Main Products

Pharmaceutical products

Company Description

PT. Tempo Scan Pacific Tbk. (TSPC) operates in the pharmaceutical business. TSPC's product lines include Hemaviton, NEO Hormoviton, Zevit-C, Bodrex, Bodrexin, NEO Rheumacyl, OBB, Candyvit-C and Flucyl among others. TSPC's business segments are divided into three categories: pharmaceutical, personal care and cosmetics, and distribution services. TSPC's subsidiaries operates in the distribution, food and beverages, cosmetics, financial services, research and development, advertising and marketing, trading and…

More

Basic Information

Total Employees:
()
Outstanding Shares:
: ()
Financial Auditors:
()

EMIS Benchmark Score

View all parameters in Benchmark Score

Quote Chart

Quote Summary

Last Price 2,000.00
Volume 314,900
Turnover 637,672,500
Index Jakarta Composite Index
Market Bursa Efek Indonesia
Ticker TSPC
Market Cap Market Cap 9,000,000,000
52 Week High 2,320.00
52 Week Low 1,670.00
Price to Earnings (P/E) 17
Earnings per Share (EPS) 115
Dividend Yield 75 (Desember 31, 2013)
Bookvalue 6,197,608,383
Enterprise Value 7,355,174,114
Quote updated on December 05, 2016
Note: data in IDR Thousands.

Key Executives

President
More

Ownership Details

Pt Bogamulia Nagadi
78.31%
Other

Key Stats

Select Items to chart them. 2016 Q3C
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss)
Total assets 6,538,356,336
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Consolidated
Source: World's Vest Base, EMIS Company Database.

Financials

Competitors - Indonesia

IDR | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2015
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest